MX2016001100A - Proceso mejorado para preparar la forma cristalina iv del posaconazol. - Google Patents

Proceso mejorado para preparar la forma cristalina iv del posaconazol.

Info

Publication number
MX2016001100A
MX2016001100A MX2016001100A MX2016001100A MX2016001100A MX 2016001100 A MX2016001100 A MX 2016001100A MX 2016001100 A MX2016001100 A MX 2016001100A MX 2016001100 A MX2016001100 A MX 2016001100A MX 2016001100 A MX2016001100 A MX 2016001100A
Authority
MX
Mexico
Prior art keywords
preparation
posaconazole
crystalline form
improved process
relates
Prior art date
Application number
MX2016001100A
Other languages
English (en)
Other versions
MX370849B (es
Inventor
Andreas Hotter
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of MX2016001100A publication Critical patent/MX2016001100A/es
Publication of MX370849B publication Critical patent/MX370849B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Abstract

La presente invención se refiere a un proceso a gran escala mejorado, para la preparación de posaconazol forma IV.
MX2016001100A 2013-07-25 2014-07-24 Proceso mejorado para preparar la forma cristalina iv del posaconazol. MX370849B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13178018 2013-07-25
PCT/EP2014/065914 WO2015011224A1 (en) 2013-07-25 2014-07-24 Improved process for the preparation of crystalline form iv of posaconazole

Publications (2)

Publication Number Publication Date
MX2016001100A true MX2016001100A (es) 2016-04-25
MX370849B MX370849B (es) 2020-01-08

Family

ID=48856541

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016001100A MX370849B (es) 2013-07-25 2014-07-24 Proceso mejorado para preparar la forma cristalina iv del posaconazol.

Country Status (6)

Country Link
US (1) US9670188B2 (es)
EP (1) EP3024828B1 (es)
CN (1) CN105579448B (es)
CA (1) CA2919290A1 (es)
MX (1) MX370849B (es)
WO (1) WO2015011224A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1064685C (zh) 1993-12-21 2001-04-18 先灵公司 四氢呋喃抗真菌剂
IL118464A (en) 1995-06-02 2000-08-13 Schering Corp (2R-cis)-4-¬4-¬4-¬4¬¬-5-(2',4 dihalophenyl)-tetrahydro-5-(1-H-1,2,4,triazol-1-yl-methyl)furan-3-yl(methoxy¾phenyl¾-1-piperazinyl¬phenyl2,4,dihydro2¬(5)-1-ethyl-2-(5)hydroxy propyl¾-3H-1,2,4-triazol-3-one and pharmaceutical compositions comprising them
ATE263163T1 (de) 1997-10-07 2004-04-15 Schering Corp Krytallinischer fungizider polymorph
EP2141159A1 (en) * 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
EP2571871B1 (en) * 2010-05-19 2017-06-21 Sandoz AG Process for the preparation of chiral triazolones
WO2013042138A2 (en) * 2011-09-19 2013-03-28 Msn Laboratories Limited Process for the preparation of triazole antifungal drug, its intermediates and polymorphs thereof

Also Published As

Publication number Publication date
MX370849B (es) 2020-01-08
CN105579448B (zh) 2018-12-21
CN105579448A (zh) 2016-05-11
EP3024828A1 (en) 2016-06-01
US20160168133A1 (en) 2016-06-16
WO2015011224A1 (en) 2015-01-29
CA2919290A1 (en) 2015-01-29
EP3024828B1 (en) 2017-05-17
US9670188B2 (en) 2017-06-06

Similar Documents

Publication Publication Date Title
MX2015016535A (es) Metodo de produccion para tagatosa.
EP3008048A4 (de) Verfahren zur herstellung von 5-hydroxymethylfurfural (hmf)
SI3027634T1 (sl) Proces za pripravo tulatromicina
IN2013MU00646A (es)
FR3003861B1 (fr) Nouveau procede de preparation de polyols-glycosides
IN2013MU03641A (es)
IL245474B (en) Process for preparing 5-fluoro-1h-pyrazoles
EP3014628B8 (en) Process of generating germanium-68
IN2014MU00455A (es)
IL245476A0 (en) Process for preparing 5-fluoro-1h-pyrazoles
IN2013MU03070A (es)
IN2013MU01113A (es)
HUE040536T2 (hu) Eljárás halogén-N,N-dimetilbenzilaminok elõállítására
IN2014DN09451A (es)
IL229326A (en) Process for making n-iodine-affluent
MA40447A (fr) Composition pharmaceutique orale d'isotrétinoïne
IN2013MU04056A (es)
PL2883461T3 (pl) Sposób wytwarzania aktywnej folistatyny
IN2013MU01290A (es)
IL239815B (en) Process for preparing derivatives of 4-methylpent-3-en-1-ol
IN2014CH00444A (es)
IN2013MU02528A (es)
MX2015011881A (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.
IN2013MU01219A (es)
IN2013MU03768A (es)

Legal Events

Date Code Title Description
FG Grant or registration